Morningstar stock pressured by revenue deceleration, says Redburn By Investing.com
[ad_1] On Wednesday, Redburn-Atlantic adjusted its stance on Morningstar (NASDAQ:MORN), changing the stock’s rating from Buy to Neutral. The firm set a price target for Morningstar at $340.00, citing multiple factors influencing the decision. The analyst at Redburn-Atlantic noted that although Morningstar’s management has taken decisive action on reducing headcount and controlling expense growth, the […]
Biden expected to speak to Netanyahu on Wednesday, Iran in focus By Reuters
[ad_1] By Trevor Hunnicutt WASHINGTON (Reuters) -U.S. President Joe Biden is expected to speak on Wednesday with Israeli Prime Minister Benjamin Netanyahu, talks set to include discussion of any plans to strike Iran, according to a person familiar with the matter. The Middle East has been on edge awaiting Israel’s response to a missile attack […]
China stocks get a reality check; Europe shudders By Reuters
[ad_1] A look at the day ahead in European and global markets from Tom Westbrook Gravity brought China’s soaring stock market back to earth with a thud on Wednesday. Disappointment about the lack – so far – of follow-through on stimulus promises has triggered a pullback in a spectacular rally and could be a harbinger […]
Scholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants By Investing.com
[ad_1] CAMBRIDGE, Mass.–(BUSINESS WIRE)–Scholar Rock Holding Corporation (Nasdaq: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced the pricing of an upsized underwritten public offering of 10,265,488 shares of its common stock at […]
NZ’s central bank cuts rates 50 bps, leaves door open for more easing By Reuters
[ad_1] By Lucy Craymer WELLINGTON (Reuters) -New Zealand’s central bank slashed the cash rate by 50 basis points to 4.75% on Wednesday and left the door open for more easing as policymakers said monetary conditions are still restrictive even though inflation has returned to target. The decision was in line with market pricing and most […]
Zoom’s chief accounting officer sells over $330k in stock By Investing.com
[ad_1] Zoom Video Communications , Inc. (NASDAQ:) has reported a significant stock transaction involving its Chief Accounting Officer, Shane Crehan, according to a recent SEC filing. The executive sold a total of 4,861 shares of Class A Common Stock over two separate transactions on October 7 and October 8, 2024. On October 7, Crehan sold […]
Woodside Completes Acquisition of Tellurian By Investing.com
[ad_1] HOUSTON–(BUSINESS WIRE)–Woodside has completed the acquisition of Tellurian (NYSE:) Inc. (Tellurian) and its US Gulf Coast Driftwood LNG development opportunity. Woodside (OTC:) has acquired all issued and outstanding Tellurian common stock for approximately $900 million cash, or $1.00 per share. The implied enterprise value is approximately $1,200 million.1 Woodside is pleased to also announce […]
Regional Management Corp. expands credit facility to $125 million By Investing.com
[ad_1] Regional Management Corp . (NYSE:), a consumer finance company, has amended its credit agreement, increasing its borrowing capacity from $75 million to $125 million, as reported in a recent SEC filing. The amendment, effective as of last Thursday, also extends the commitment termination date to October 15, 2026. The Greer, South Carolina-based company, along […]
InMode stock touches 52-week low at $14.93 amid market challenges By Investing.com
[ad_1] In a challenging market environment, InMode Ltd . (NASDAQ:) stock has reached its 52-week low, trading at $14.93. The medical technology company, known for its innovative minimally invasive treatments, has faced significant headwinds over the past year, reflected in a substantial 1-year change with a decline of -46.17%. Investors have shown concern as the […]
Scilex reports growth in Q3 net sales for pain management products By Investing.com
[ad_1] PALO ALTO, Calif. – Scilex Holding Company (NASDAQ:SCLX), a company specializing in non-opioid pain management therapies, has announced preliminary unaudited financial results for the third quarter ending September 30, 2024. The company reported that net sales of ZTlido, its lidocaine topical product, were between $11.0 million and $13.0 million, marking an increase from $10.1 […]